Genpact Limited (NYSE:G): A Fundamentally Weighted Stock for Long-Term Investors

Genpact Limited (NYSE:G) has a beta of 1.40, a 12-month trailing P/E ratio of 26.88, and a growth ratio of 2.48. The stock’s Relative Strength Index (RSI) is 58.44, with weekly volatility at 3.34% and ATR at 1.21. The G stock’s 52-week price range has touched low of $19.41 and a $43.94 high. Its shares traded higher over the last trading session, gaining 1.72% on 03/10/21. The shares fell to a low of $41.61 before closing at $42.49. Intraday shares traded counted 1.6 million, which was -34.1% lower than its 30-day average trading volume of 1.19M. G’s previous close was $41.77 while the outstanding shares total 189.47M.

Investors have identified the Information Technology Services company Genpact Limited as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $7.72 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Genpact Limited (G) Fundamentals that are to be considered.

When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For G, the company has in raw cash 680.44 million on their books with 283.54 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.75 billion total, with 1.2 billion as their total liabilities.

Having a look at the company’s valuation, the company is expected to record 2.31 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on G sounds very interesting.

Is the stock of G attractive?

In related news, Chief Financial Officer, Fitzpatrick Edward J. sold 30,583 shares of the company’s stock in a transaction that recorded on Mar 08. The sale was performed at an average price of 41.94, for a total value of 1,282,669. As the sale deal closes, the Senior Vice President, Cogny Patrick now sold 24,553 shares of the company’s stock, valued at 1,019,286. Also, Senior Vice President, Mehta Piyush sold 70,000 shares of the company’s stock in a deal that was recorded on Feb 09. The shares were price at an average price of 43.00 per share, with a total market value of 3,010,000. Following this completion of acquisition, the SVP & General Counsel, White Heather now holds 15,513 shares of the company’s stock, valued at 638,250. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.70%.

6 out of 10 analysts covering the stock have rated it a Buy, while 3 have maintained a Hold recommendation on Genpact Limited. 0 analysts has assigned a Sell rating on the G stock. The 12-month mean consensus price target for the company’s shares has been set at $48.38.

Leave a Comment

Your email address will not be published. Required fields are marked *